Aeglea BioTherapeutics Inc. (AGLE) gained 5.43% or 0.5 to $9.71. It is approximately 55213 shares traded, which is 19.26% compare to the average total volume 286625. The market cap of AGLE is $213.57 million. The year to date change is 76.62%. The 52 week price range is from $3.75 to $12.0. Price of AGLE have changed -0.65% during last week. It have changed -0.32% over last month, -16.27% over last 3 months, -4.26% over last 6 months and 83.83% over one year.
Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for AGLE is 9.25. It is -4.74% below current price. The 200-day Moving Averages for AGLE is 8.62. It is -11.23% below current price. The 52-week High is 12.0. It is 23.58% from the current price. The 52-week Low is 3.75. It is -61.38% from current price.
Some people may be interesting about short interest ratio of a stock. The short interest ratio of AGLE is 2.79 on 2018-09-14. Short % to float is 2.83%. There are some statistics of AGLE. It is has market cap $213.57 million. The share outstanding is 22.00 million. The average volume is 286625. The revenue is 1.26M. The percent of top 15 Institution holding is 62.40%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of AGLE is -46.88%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of AGLE is -43.43%.